Maynard Consulting

Activities: Regulatory Pharmaceutical

Trending Articles

  1. Lowering the chance of antimicrobial resistance with built in agents Antimicrobial additives have key differences to disinfectants and antibiotics which make them a great solution that keeps organisms from surviving and evolving into resistant...
  2. ESMC breaks ground on its first semiconductor fab in Germany European Semiconductor Manufacturing Company (ESMC) held a groundbreaking ceremony to officially mark the initial phase of land preparation for its first semiconductor fab in...
  3. Swedish Nefab opens 25,000 sqft semiconductor packaging facility in Penang suburb The new facility in Batu Kawan, Malaysia, contains a cleanroom that will become operational in 2025
  4. Symbiosis acquires a 20,000 sq/ft building financed by Barclays Corporate Bank Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1.2m from Barclays Corporate Bank PLC
  5. Sterile transfer expert ABC Transfer chooses exclusive distributor in Italy Amira has been chosen by ABC to be the exclusive distributor of ABC Transfer Rapid Transfer Port products in Italy

Upcoming event

DCAT Week

16-20 March, 2025 | Conference | New York, US See all

Related Content

Regulatory

The GMP timeline of adverse event resolution

Regulatory expert Joy McElroy on managing GMP complaints and the steps to resolve incidents ahead of a product recall
Regulatory

Editor's comment: The devil is in the detail

Common issues that lead to GMP failures are caused by the desensitisation to the value of genuine quality
Pharmaceutical

Joy McElroy | GMP Consultant

The US-based pharmaceutical manufacturing expert sets the record straight on quality assurance. “Quality is of utmost priority, and top-level management must understand this. We must teach GMPs to them,” she says
Subscribe now